<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>BioGen Industries – Leadership</title>

    <!-- Global stylesheet -->
    <link rel="stylesheet" href="style.css">

    <!-- Favicon -->
    <link rel="icon" type="image/png" href="biogen_favicon.png">
</head>

<body class="static-nav-page">
<!-- ----------------------------- -->
<!--         NAVIGATION BAR        -->
<!-- ----------------------------- -->
<header class="navbar navbar-static">
    <div class="nav-left">
        <img src="biogen_logo_nav_black.webp" class="nav-logo" alt="BioGen Industries">
    </div>

    <nav class="nav-links">
        <a href="index.html">Home</a>
        <a href="bgres.html">Research</a>
        <a href="bgman.html" class="active">Leadership</a>
        <a href="careers.html">Careers</a>
        <a href="#contact">Contact</a>
    </nav>

    <!-- HAMBURGER FOR MOBILE -->
    <div class="hamburger">
        <span></span><span></span><span></span>
    </div>
</header>

<!-- MOBILE MENU -->
<div class="mobile-menu">
    <a href="index.html">Home</a>
    <a href="bgres.html">Research</a>
    <a href="bgman.html">Leadership</a>
    <a href="careers.html">Careers</a>
    <a href="#contact">Contact</a>
</div>


<!-- ----------------------------- -->
<!--        PAGE INTRO HEADER      -->
<!-- ----------------------------- -->
<section class="page-header fade-in-up">
    <h1>Meet Our Leadership Team</h1>
    <p>
        BioGen Industries is guided by a multidisciplinary team of scientific and strategic leaders dedicated 
        to advancing haemological research, developing innovative diagnostics, and ensuring responsible practice 
        across our organisation.
    </p>
</section>


<!-- ----------------------------- -->
<!--     LEADERSHIP PROFILES       -->
<!-- ----------------------------- -->
<section class="team-section">

    <!-- OCTAVIAN -->
    <article class="profile fade-in-up">
        <img src="tavi.jpg" alt="Dr Octavian Juul">

        <div>
            <h2>Dr Octavian Juul</h2>
            <h3>Managing Director</h3>

            <p>
                Dr Juul began his scientific career in the early 1970s, completing a doctorate in neurochemistry 
                at the Université Descartes in Paris. His early research focused on metabolic deficiencies and 
                enzyme-linked blood disorders, helping lay groundwork for several modern therapeutic approaches.
            </p>

            <p>
                After senior appointments at the Wellside Foundation, Dr Juul co-founded BioGen Industries with 
                Dr Katerina Marin. Under his leadership, the organisation has expanded its partnerships, supported 
                early-career researchers, and established a stable research ecosystem for long-term development.
            </p>

            <p>
                Though no longer a laboratory researcher, Dr Juul continues to oversee governance, strategy, and 
                ethical direction across BioGen’s scientific portfolio.
            </p>
        </div>
    </article>

    <!-- KATERINA -->
    <article class="profile fade-in-up">
        <img src="Kat.jpg" alt="Dr Katerina Marin">

        <div>
            <h2>Dr Katerina Marin</h2>
            <h3>Director of Research</h3>

            <p>
                Dr Marin began her medical career as an endocrinologist before completing her doctorate focusing on 
                clotting disorders, particularly Plasminogen Activator Inhibitor Type 1 deficiency. Her research 
                experience spans institutions across Europe and the United States.
            </p>

            <p>
                At BioGen, she leads the organisation’s research portfolio, overseeing programmes in rare disease 
                investigation, emerging diagnostics, behavioural interactions, and long-term physiological outcomes 
                associated with bloodborne conditions.
            </p>

            <p>
                Dr Marin continues to direct several core projects and maintains a central role in the company’s 
                scientific direction and international partnerships.
            </p>
        </div>
    </article>

    <!-- JOHANNES -->
    <article class="profile fade-in-up">
        <img src="Johan.jpg" alt="Johannes Rehema">

        <div>
            <h2>Johannes Rehema</h2>
            <h3>Head of People</h3>

            <p>
                Mr Rehema brings extensive experience in organisational strategy, internal development, and corporate 
                governance. He holds an MBA from the University of Cambridge Judge Business School, graduating with distinction.
            </p>

            <p>
                Before joining BioGen, he worked at PricewaterhouseCoopers and Deloitte, specialising in restructuring 
                and operational transformation. His work at BioGen focuses on staff wellbeing, regulatory compliance, 
                and sustainable organisational growth.
            </p>

            <p>
                Mr Rehema oversees HR policy, recruitment frameworks, internal culture, and long-term operational planning.
            </p>
        </div>
    </article>

</section>


<!-- ----------------------------- -->
<!--            FOOTER             -->
<!-- ----------------------------- -->
<footer class="footer" id="contact">
    <p><strong>Contact Us</strong></p>

    <p>
        Email: 
        <a href="mailto:biogen@techcenter.com">biogen@techcenter.com</a><br>
        16 The Edge Business Centre<br>
        Dollis Hill, London, NW2 6<br>
        United Kingdom
    </p>

    <div class="footer-logos">
        <img src="AMRC1.png" alt="AMRC Membership" height="70">
        <img src="AMRC2.png" alt="AMRC Accredited" height="70">
    </div>

    <p class="footer-copy">© 2025 BioGen Industries. All rights reserved.</p>
</footer>


<!-- GLOBAL SCRIPTS -->
<script src="scripts.js"></script>

</body>
</html>
